Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_assertion description "[As a result, the IC50 values of 24 anticancer drugs obtained from the brain cancer cells clearly showed patient cell-specific efficacy, some of which were well-correlated with their oncogene overexpression (c-Met and FGFR1) as well as the in vivo previous results of the mouse xenograft model with the three primary brain cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_assertion evidence source_evidence_literature NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_assertion SIO_000772 24199994 NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_assertion wasDerivedFrom befree-20150227 NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_assertion wasGeneratedBy ECO_0000203 NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP400445.RAl1vqh0QfHWC_jlOi2Xo5F4djisMF7LN1c6Nsg5nm-yg130_provenance.